Related Experiment Videos
ATP-sensitive K+ channel openers inhibit morphine withdrawal
L I Robles1, M Barrios, J M Baeyens
1Department of Pharmacology, Medical School, University of Granada, Spain.
European Journal of Pharmacology
|January 4, 1994
Summary
Two ATP-sensitive K+ channel openers, cromakalim and diazoxide, reduced morphine withdrawal symptoms in mice. These compounds may act as substitutes for morphine during withdrawal by mimicking its effects on neuronal K+ currents.
Area of Science:
- Neuropharmacology
- Opiate Dependence Research
Background:
- Morphine dependence is a significant clinical challenge.
- Naloxone-precipitated withdrawal is a model for studying opiate withdrawal symptoms.
Purpose of the Study:
- To investigate the effects of ATP-sensitive K+ channel openers on naloxone-precipitated morphine withdrawal.
- To explore potential therapeutic strategies for managing morphine withdrawal.
Main Methods:
- Administration of cromakalim and diazoxide (ATP-sensitive K+ channel openers) via intracerebroventricular (i.c.v.) injection in morphine-dependent mice.
- Dose-dependent assessment of withdrawal signs including jumps, forepaw tremors, and body weight loss.
Main Results:
- Both cromakalim and diazoxide dose-dependently inhibited key signs of morphine withdrawal.
- Observed reductions in the number of jumps, episodes of forepaw tremors, and body weight loss.
Conclusions:
- ATP-sensitive K+ channel openers show potential in mitigating morphine withdrawal symptoms.
- These compounds may substitute for morphine by influencing neuronal K+ currents, offering a novel therapeutic avenue.